Home > Income Statement > AARTI PHARMALABS

AARTI PHARMALABS
Revenue

    Back to Income Statement
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,945 Cr₹1,200 Cr--

What is the latest Revenue of AARTI PHARMALABS ?

The latest Revenue ratio of AARTI PHARMALABS is ₹1,945 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,945 Cr
Mar2023₹1,200 Cr
Mar2022-
Mar2021-

How is Revenue of AARTI PHARMALABS Trending?

Years Revenue % Change
Mar2024 ₹1,945 Cr
62.11
Mar2023 ₹1,200 Cr
0
Mar2022 -
0
Mar2021 - -

Compare Revenue of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,129.5 Cr 2.9% -0.8% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,584.0 Cr 0.5% 0.6% 9.5% Stock Analytics
DIVIS LABORATORIES ₹182,147.0 Cr 3.7% 5.1% 49.1% Stock Analytics
CIPLA ₹120,941.0 Cr -1% 1.7% 2.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,325.0 Cr 3.8% 6.8% 22.5% Stock Analytics
DR REDDYS LABORATORIES ₹106,138.0 Cr -3.7% 1.9% -0.3% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

2.9%

-0.8%

49.4%

SENSEX

0.8%

2.5%

5.3%


You may also like the below Video Courses